An HIV breakthrough is here. Let's not let it go to waste

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...
Hosted on MSN

Lenacapavir approved by FDA: What it means for HIV prevention

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
EurekAlert!

Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents

Despite many oral, once daily, medications for treatment for adolescents with Human Immunodeficiency Virus (HIV), many ...
Medscape

Which Regimen Works Best for Late-Diagnosis HIV Care?

Researchers conducted a retrospective, multinational study across 15 European treatment centers to assess the efficacy and tolerability of DTG/3TC vs BIC/TAF/FTC as first‑line therapy in ...
Business Wire

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment ...
Men's Health on MSN

New Science May Finally Outsmart the HIV Virus

This piece is part of “The Cure for Everything:” A series of stories that looks at the breakthroughs, setbacks, and overall status of vaccines and cures for hard-to-treat diseases and viruses, from ...